Squamous cell carcinoma | Adenocarcinoma | |
---|---|---|
Gender | ||
Male | 28 | 28 |
Female | 3 | 4 |
Tumour size T | ||
T1 | 7 | 8 |
T2 T3 | 13 10 | 13 8 |
T4 | 1 | 2 |
Nodal status N | ||
N0 | 18 | 13 |
N1 | 7 | 10 |
N2 | 4 | 7 |
N3 | 1 | 2 |
Metastasis M* | ||
M0 | 31 | 22 |
M1 | 0 | 10 |
CD68 | ||
II: 5-30% | 2 | 1 |
III: 30-80% | 29 | 31 |
Gas6 | ||
I: < 5% | 19 | 16 |
II 5-30% | 10 | 14 |
III 30-80% | 2 | 2 |
Cox2 | ||
II: 5-30% | 3 | 2 |
III: 30-80% | 28 | 30 |
MMP2 * | ||
II: 5-30% | 15 | 5 |
III: 30-80% | 16 | 27 |
Notch3 | ||
II: 5-30% | 4 | 6 |
III: 30-80% | 27 | 26 |
Survival status at census | ||
Dead | 23 | 28 |
Alive | 8 | 4 |
Medians (nonparametric 95% confidence interval) | ||
Age | 70 (65-71) | 64 (59-69) |
Survival time (month) | 25 (14-71) | 16.5 (11-34) |